|
Commonwealth Biotechnologies, Inc. - Company Profile Snapshot
| Company Profile: |
Commonwealth Biotechnologies, Inc. |
| Ticker: |
CBTE |
| Exchanges: |
NAS |
| 2008 Sales: |
9,435,500 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Service Organizations |
| Country: |
UNITED STATES |
| Employees: |
65 |
Business Description
Commonwealth Biotechnologies, Inc.. The Group's principal activity is to provide solutions to the global biotechnology industry, academic institutions, genetic identity, laboratory services, commercial contracts, government agencies and pharmaceutical companies. It provides integrated contract research support in four principal areas: bio-defense; laboratory support services for on-going clinical trials; comprehensive contract projects in the private sector; and through it FIL division, for paternity testing, forensic case-work analysis and CODIS work. The Group also provides sophisticated macromolecular synthetic and analytical services, integrating individual platform technologies. The Group facilitates strategic decisions to both short term and long term clients. It operates only in the United States. On 23-Sep-2008, the Group discontinued Exelgen Limited.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
